Residual Paralysis and Reversal With Routine Neostigmine Versus Half-dose Sugammadex and Routine Neostigmine

NCT05066035 PHASE4 COMPLETED

Sugammadex may prevent residual neuromuscular blockade by providing rapid reversal at the end of the operation. Our goal is to compare the half-dose use of sugammadex for reversing residual blockade after administration of neostigmine and atropine to the routine use of reversal medication.

Details

Lead sponsor	Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital
Phase	PHASE4
Status	COMPLETED
Enrolment	113
Start date	Wed May 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Dec 30 2016 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Neuromuscular Blockade
• Sugammadex
• Neostigmine
• Complication of Anesthesia
• Postoperative Residual Curarization
• Rocuronium

Interventions

• Neostigmine
• Sugammadex